Thursday, Aug 28, 2014
The ALS Ice Bucket Challenge continues to sweep across the nation, leaving many people completely soaked (and with lighter wallets after donating to the cause!) but still curious about the specifics of the disease itself.
Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. It can strike anyone of any age at any time, robbing individuals of the ability to walk, talk, swallow, and breathe. According to the ALS Association, approximately 5,600 people in the United States are diagnosed with ALS each year, but there is no known cause, treatment or cure. The average life expectancy is about two to five years after being diagnosed, but certain therapies are available that have been shown to help slow the progression of the disease.
“Harbin Clinic’s Neurology team helps diagnose and manage the course of ALS, which includes using supportive treatment measures to help prolong a person’s life,” said Dr. David Hale, chairman of Harbin Clinic’s Neurology practice. “While there is still much to learn about ALS, my colleagues and I are hopeful that the funds and awareness raised from the Ice Bucket Challenge may lead to a better understanding of the disease process and, most importantly, a cure."
Harbin Clinic Neurology offers a full range of diagnostic services and treatment in both Rome and Cartersville for a variety of neurological conditions and diseases. For more information about our Neurology practice, visit http://harbinclinic.com/neurology. For more information about ALS, visit www.ALSA.org.